KPIs & Operating Metrics(New)
Active Patients By RegionActive Patients By Region AnnualActive Patients TotalActive Patients Total, AnnualAsset Allocation By Category %Breakdown Of AssetsCost Of RevenuesDeferred RevenueEmployee StatisticsGross Margin %Gross ProfitIncome Before Taxes By RegionLong Lived Assets By RegionLong Lived Assets By Region AnnualNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Operating Expense SegregationOpex As A % Of RevenuePrescriptions Received By RegionPrescriptions Received By Region AnnualPrescriptions Received By Region Annual, TotalPrescriptions Received TotalProperty And Equipment, NetR&D And Clinical Trial Expenses By ProgramReceivables And Prepaid ExpensesRevenue By Customer'S LocationRevenue By Customer'S Location %Revenue By Customer'S Location AnnualRevenue By Customer'S Location Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

NovoCure (NVCR) Gross Profit (2023 - 2025)

NovoCure (NVCR) has disclosed Gross Profit for 12 consecutive years, with $132.2 million as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 3.44% to $132.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $488.5 million through Dec 2025, up 4.37% year-over-year, with the annual reading at $488.5 million for FY2025, 4.37% up from the prior year.
  • Gross Profit hit $132.2 million in Q4 2025 for NovoCure, up from $122.5 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $132.2 million in Q4 2025 to a low of $92.0 million in Q2 2023.
  • Historically, Gross Profit has averaged $109.0 million across 5 years, with a median of $106.6 million in 2021.
  • Biggest five-year swings in Gross Profit: skyrocketed 40.06% in 2021 and later decreased 18.09% in 2023.
  • Year by year, Gross Profit stood at $103.5 million in 2021, then decreased by 3.85% to $99.5 million in 2022, then grew by 1.69% to $101.2 million in 2023, then increased by 26.25% to $127.8 million in 2024, then increased by 3.44% to $132.2 million in 2025.
  • Business Quant data shows Gross Profit for NVCR at $132.2 million in Q4 2025, $122.5 million in Q3 2025, and $117.3 million in Q2 2025.